Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2004
[Ocular side effects and complications of intravitreal triamcinolone acetonide injection].
Аннотация на английскомСтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jaissle G B, Szurman P, Bartz-Schmidt K U
Аннотация
With the advent of intravitreal triamcinolone acetonid injections major focus was assigned to potential ocular side effects. The current discussion is dominated by the potential cytotoxicity of particular biologically incompatible components. Those are regarded as substantial pathogenetic factor of the sterile pseudoendophthalmitis that seems to be avoidable by meticulous purification of the commercially available preparations. Even sustained subretinal or epiretinal deposits disclosed no signs of retinal toxicity. Major ocular side effects comprise temporary corticosteroid glaucoma and progressive cataract formation. Infectious endophthalmitis represents a rare but serious complication that might be set into critical context with hygienic surgical standards applied. Due to steroid-induced immune suppression clinical signs of inflammation might be masked and a proper diagnosis delayed. Other rare complications reported include a transient central retinal artery occlusion, conjunctival ulcerations, retinal detachment and potential reactivation of a cytomegalovirus retinitis. In conclusion, ocular side effects and complications show a wide variety of clinical signs and underlying causal mechanisms. However, the consequences are mostly temporary and show a good response to therapeutic intervention.
Предметные рубрики MeSH
Anti-Inflammatory AgentsCataractConjunctival DiseasesControlled Clinical Trials as TopicEndophthalmitisEye DiseasesGlaucomaGlucocorticoidsHumansImmunosuppressive AgentsInjectionsMiddle AgedMulticenter Studies as TopicRetinaRetinal Artery OcclusionRetinal DetachmentRetrospective StudiesTime FactorsTriamcinolone AcetonideUlcerVitreous Body